Converium Capital called on CVS GROUP PLC to launch a £100 million ($135 million) share buyback and improve operational performance. This demand follows failed private discussions between the Montreal-based hedge fund and the United Kingdom veterinary services provider. Investors are weighing whether the board will shift capital allocation toward shareholders to reverse an 18.5% share price decline.

Activist Pressure Mounts After Private Talks Stall